Led · Equity · Dec 2025

Phanofi is a deep-tech startup building photonic chips that exploit three dimensions of light—polarization, intensity, and phase—to move up to four times more data than current interconnect technology. The chips are designed to be integrated into pluggable modules for data-center networks, making interconnect links roughly 30 % more power-efficient and delivering an overall data-center energy reduction of nearly 10 %. Over the past year, the company expanded its team from five to ten employees and secured €4.5 million in new funding. Phanofi participated in Innovationsfonden’s Innofounder program, which provided mentorship and resources as the founders transitioned from engineers to leaders. The immediate objective is to advance from prototype to first commercial product. Looking ahead, management plans to raise a seed round in spring 2026 to scale production and envisions building a global fab-less photonic design house with a potential multi-billion-dollar exit within the next decade.

Led · Grant · Feb 2024

Commit Biologics is developing the Bispecific Complement Engaging (BiCE™) platform, a modular system that uses single‑domain antibodies to engage C1q and direct complement activation against tumor and autoimmune targets. The technology can arm conventional antibodies to enhance complement‑mediated cytotoxicity and modulate innate and adaptive immune responses. Commit spun out of Aarhus University and builds on more than three decades of research. Since emerging from stealth last May, the company has progressed its platform toward drug candidate selection. Proceeds from the recent financing will be used to advance BiCE and work toward drug candidate (DC) selection. The company says the extension of funding extends its cash runway into late 2026. Commit Biologics develops therapies that activate the complement system to kill specific target cells, with applications in cancer and autoimmune disease. Its core product is the Bispecific Complement Engaging (BiCE™) platform, a modular system that can arm antibodies to direct the complement system to selectively kill cancer cells or immune cells that drive autoimmune diseases. The platform is designed to leverage established antibodies, which the company says can cut development times and reduce risk. Commit plans to use the €16M seed financing to accelerate development of the BiCE™ platform. The company was spun out of Aarhus University and builds on more than three decades of research into complement biology. Commit is led by CEO Krishna Polu. Commit Biologics is developing the BiCE technology to fight cancer. The company announced it has received a 5M DKK Innobooster grant from the Innovation Fund Denmark (IFD). The grant is intended to support further development of the BiCE technology. Aarhus University Technology Transfer posted congratulations on LinkedIn about the boost. The funding is presented as an Innobooster grant rather than equity or debt; no additional financial details were disclosed in the article.

Participated · Seed · Mar 2023

Tryp.com is a Copenhagen-based travel platform that consolidates bookings for flights, trains, buses and accommodation into a single AI-driven interface. Founded in 2020 by André Sousa, Hélio Domingos, Inês Jorge, Sebastian Nørgaard and Victor Thomsen, the platform was developed by engineering students, released a beta in 2021 and went public in 2022. It leverages technology to scan “millions” of travel options and lists 28 million accommodation options across more than 7,000 cities. The company has facilitated over 18 million trips for 3 million users and is building virtual interlining technology to simplify multi-destination logistics. In 2024 Tryp increased marketing spend by 27% and achieved 2.3x revenue growth, 2.1x growth in tickets sold, and a 57% improvement in conversion after investing in machine learning. It also introduced Sandra, an AI travel assistant that handled over 24k conversations, and recently rebranded with new profile and booking management pages as it scales through 2025. Tryp.com operates a travel planning platform that helps users find affordable trip options by inputting available dates and a departure country. The company is Copenhagen-based and has seen rapid growth, reaching more than 1 million users in the last 12 months. Tryp.com closed a seed round of an undisclosed amount north of €500,000, bringing its valuation to €8.3 million. The new capital is intended to scale the company, grow the team, enhance its technology, and expand its reach. Co‑founders André Sousa (CEO) and Inês Jorge (head of data) framed the funding as a milestone to make travel more accessible and to position Tryp.com as a go-to destination for trip planning. The platform emphasizes simple, wide-ranging search capability described as finding options from "anywhere to everywhere."

Participated · Seed · Nov 2022

Breye Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, Denmark, developing novel oral small-molecule therapies for retinal vascular diseases. The company is focused on de-risked small molecules suited for oral administration with a scientific rationale for treating diabetic retinopathy and age-related macular degeneration. Breye intends to use the new funding to expand its team and broaden its pipeline across a wider range of ophthalmologic diseases. The company is led by CEO Ulrik Mouritzen and is part of Novo Seeds’ company-creation efforts, with involvement from Novo Holdings’ early-stage investment team. Pre-seed support for Breye included funding from the BioInnovation Institute (BII), the Danish Growth Foundation (Vækstfonden) and the Danish Innovation Foundation (Innovationsfonden).

Led · Grant · Sep 2022

Hypefactors offers an integrated, AI-powered earned-media tech platform that combines data, analytics, technology and tools to support media intelligence, reputation and trust management. The platform provides media monitoring across channels plus automated documentation of the monetary value and quality assessment of third-party media mentions. It also includes time-saving features such as automatically generated media reports and a mobile app for real-time media mentions. The company is listed on Nasdaq Growth Market in Copenhagen, Denmark. Recent corporate actions—an equity capital increase, a new loan facility and pending state-backed loan tranches—are intended to strengthen the company’s capital structure. Management says these measures will have a positive effect on both liquidity and equity. Hypefactors is an integrated AI-powered earned media tech platform that combines data, analytics, technology and tools to support media intelligence, reputation and trust management. The platform automates media monitoring across channels and provides features including automated documentation of the monetary value and quality assessment of each third-party media mention, automatically generated media reports, and a mobile app for real-time media mentions. The company announced an Innovation Fund Denmark Innobooster grant to support development of a "New Print PDF Processing Program" to expand its print-coverage capabilities. The project will apply recent breakthroughs in computational linguistics (NLP) and AI techniques beyond machine learning, including an automated reasoning engine and probabilistic programming, to process printed news (newspapers and magazines). The project kicked off in October 2022 and is expected to be finalized within approximately 10 months. Hypefactors is listed on Nasdaq Growth Market in Copenhagen, Denmark. Hypefactors is an AI-powered earned media tech platform that provides real-time monitoring of global and local media mentions and reputation/trust metrics for companies, brands, competitors, industries and trends. The platform combines data, analytics and tools including automated documentation of the monetary value and quality assessment of third-party media mentions, auto-generated media reports, and a mobile app for real-time mentions. The company is listed on Nasdaq Growth Market in Copenhagen. Management has stated it will tune marketing and sales to add more clients and revenue. In March 2022 Hypefactors completed a capital increase and accompanying financing actions intended to improve liquidity, strengthen equity and clean up the balance sheet. The filings state the financings will have a positive effect on both liquidity and equity and benefit the company’s capital structure. Hypefactors is an integrated AI-powered earned media tech platform that provides real-time media monitoring and reputation metrics for companies, brands, competitors, industries and trends. The platform combines data, analytics and tools to automate media monitoring across channels, including automated documentation of monetary value and quality assessment of each third-party media mention, automatically generated media reports, and a mobile app for real-time access. The company is listed on Nasdaq Growth Market in Copenhagen, Denmark. Management and early investors participated in a capital increase that strengthens the company’s capital structure. The capital increase issued 154,149 new shares at DKK 6.4872, raising DKK 1 million, and was combined with a DKK 1 million loan from Vaekstfonden. Vaekstfonden’s second loan tranche was disbursed after Hypefactors met a specific MRR target required by the fund. Hypefactors operates an integrated AI-powered earned-media platform that delivers real-time global and local media mentions, analytics, and reputation insights. The platform automates media monitoring across channels and provides tools such as automated documentation of monetary value and quality assessment for third-party mentions. It also offers time-saving features including automatically generated media reports and a mobile app for real-time access. Hypefactors combines data, analytics, and technology to support corporate reputation management and measurement. The company is listed on the Nasdaq Growth Market in Copenhagen and is headquartered in Copenhagen, Denmark. Recent financial actions described by management are intended to strengthen liquidity and equity to support continued business growth.